Resmed (RSMDF) Change in Accured Expenses (2009 - 2026)

Resmed (RSMDF) has reported Change in Accured Expenses for 18 consecutive years, with $50.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Change in Accured Expenses rose 2.99% year-over-year to $50.6 million; the trailing twelve-month figure through Jun 2026 stood at $172.7 million (up 89.88% YoY), and the FY2026 full-year result was $172.7 million, up 89.88% from the prior year.
• Change in Accured Expenses eased to $50.6 million in Q2 2026 per RSMDF's latest filing, from $103.9 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $122.0 million in Q2 2024 and bottomed at -$34.4 million in Q4 2023.
• Historically, Change in Accured Expenses has averaged $26.4 million across 5 years, with a median of $19.2 million in 2022.
• The widest YoY moves for Change in Accured Expenses: up 36862.42% in 2024, down 2399.02% in 2024.
• Over 5 years, Change in Accured Expenses stood at -$17.3 million in 2022, then sank by 99.02% to -$34.4 million in 2023, then surged by 112.28% to $4.2 million in 2024, then jumped by 152.25% to $10.6 million in 2025, then soared by 374.95% to $50.6 million in 2026.
• According to Business Quant data, Change in Accured Expenses over the past three periods registered $50.6 million, $103.9 million, and $10.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.